Search Results

10 results for public health genomics

Suicide, Family History, and Genomics

Robin Williams speaks to troups

We must continue to search for new methods to effectively address the tremendous problem of suicide. Despite recent interest, genomics does not provide the solution today, but there is a lot that we can do now using an established public health approach to prevention.   Millions were shocked by the news that comedian Robin Williams

Posted on by Scott Bowen, OPHG and Brad Bartholow with National Center for Injury Prevention and Control, CDC StaffTags , ,

Nobody is average but what to do about it? The challenge of individualized disease prevention based on genomics

Nobody is Average- a normal distribution curve with figures inside it and DNA as the curve

  Each week, Garrison Keillor shares with National Public Radio listeners the latest news from Lake Wobegon where “all the women are strong, all the men are good looking, and all the children are above average.” The concept of “average” is deeply rooted in our scientific analysis of all health related traits such as height,

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

Public Health Impact of Genome-Wide Association Studies: Glass Half Full or Half Empty?

two half full glasses with chromosomes

Genome-wide association studies (or GWAS) are large-scale genetic investigations of human disease that measure simultaneously hundreds of thousands of genetic variants scattered throughout the human genome. GWAS burst onto the scientific scene in the mid 2000’s. Propelled by technological advances and falling prices, GWAS have revolutionized the search for genetic influences on common diseases of

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

Why We Can’t Wait: A Public Health Approach to Health Disparities in Genomic Medicine

six circles surrounding a circle including this text: Ensuring Effective and Responsible Use of Genomic Medicine to Improve Population Health. Circle 1 text: Community. Circle 2 text: Health Care Delivery System. Circle 3 text: Employers and Business. Circle 4 text: The Media. Circle 5 text: Academia. Circle 6 text: Governmental Public Health Infrastucture

In May 2013, I attended and presented at the “Why We Can’t Wait Conference to Eliminate Health Disparities in Genomic Medicine.”  The conference was organized by the University of Miami and Stanford University, with attendees and speakers from academia, consumer organizations, government agencies, public health, clinical practice, and the private sector. A key rationale for

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , , ,

From Genetic Counseling in Individuals to Cascade Screening in Populations: An Emerging Role for Public Health Practice

genetic counseling

There are more than 2500 diseases for which genetic testing is currently available. Most of these diseases are individually rare conditions but collectively affect millions of individuals and families worldwide. Genetic diseases are usually caused by mutations in one or a few genes that may confer a high risk of illness, disability and early death.

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 CommentTags ,

Evidence Matters in Genomic Medicine—Round 3: Integrating Family Health History into Clinical Preventive Services

stacked boxes with pedigree

A new podcast from the CDC Expert Commentary Series on Medscape—Family Health History: Use It to Inform Preventive Services for Your Patients— describes how family health history can inform the delivery of preventive health services.   The podcast presents three case studies based on recommendations of the US Preventive Services Task Force (USPSTF):  screening for lipid

Posted on by Katherine Kolor and Muin J Khoury, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , , , ,

What Gets Measured Gets Done: Genomics, Surveillance Indicators and Healthy People 2020

graph

Public health surveillance indicators, such as those developed for the Healthy People initiative are useful for monitoring the development of genomic medicine in the United States. For several decades, Healthy People has established health benchmarks that are considered important metrics for tracking progress in health and healthcare in the United States.

Posted on by Muin J Khoury and Katherine Kolor, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , , ,

Genomic Tests and Population Health: An Online Catalog to Promote a Conversation on Evolving Evidence

stacked boxed with A T C G on them

  With the rapid emergence of genomic tests, healthcare providers, patients and policy makers need to know how useful they are and whether the benefits of their use outweigh potential harms to patients, families, and the population. CDC’s Office of Public Health Genomics now offers a list of health-related genomic tests and applications, stratified into

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags , , , , ,

Ushering Public Health Practice into the 21st Century

Public Health Genomics

The April 2012  special issue of the journal Public Health Genomics includes 13 articles from the many presentations at the 4th National Conference on Genomics and Public Health in the United States: “Using Genetic Information to Improve Health Now and In the Future”.  The three-day conference sponsored by the Centers for Disease Control and Prevention, 

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and PreventionTags , ,

The Public Health Approach to Genetic Testing in the 21st Century: Saving Lives and Saving Unnecessary Healthcare Costs

vials on top of money

In March 2012, a prominent health insurer in the United States released a white paper entitled: “Personalized Medicine: trends and prospects for the new science of genetic testing and molecular diagnostics” By analyzing their own claims data, the report suggests that in 2010, the cost of genetic and molecular diagnostic testing for its members was about $500

Posted on by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention4 CommentsTags , , , ,